MRD / Regn No. : THBC\23-24\07062 Date : 25/06/2026
Patient Name : Gigesh Kumar Age & Gender : 41 Yrs. / Male
Contact No. : 9930565182 UHID :
Ht / Wt / BMI : 189 / 137.65 / 38.53 BP S / BP D : 155 / 90
Allergies : NONE Referred By :
   
Subjective : T2DM SINCE 2015,ADDING BACK DAPANORM TRIO - HAS TOLERATED IN PAST
Objective : 23-APR-2026 REPORTS,HB-16.8/ HBA1C-5.5%,FBS-79/ PPBS-155,CR-1.01,URICN ACID-4.7,P-2.5,AST-20/ ALT-20,TC-239/ TG-135/ LDL-160/ HDL-52,T3-89.6/ T4-10.92/ TSH-1.240,VITD-53.6/ VITB12-289,USG - GRADE 2 FATTY LIVER / NO GALL BLADDER STONES
Plan : HBA1C / SERUM AMYLASE / SERUM LIPASE  
S# Generic (Trade) Name Route Dosage Usage Duration
1 DAPANORM 10 MG ORAL 1-0-0 ABF
 2 MTHS
2 GLUCONORM G1 ORAL 1-0-1 BEFORE MEALS
 2 MTHS
3 INJ MOUNJARO 2.5 MG SC 1/WEEK ANYTIME OF DAY
 4 WEEKS
4 INJ MOUNJARO 5 MG SC 1/WEEKLY ANYTIME OF DAY
 4 WEEKS
       
Refill : 0 / Substitution:    
Education :
Next Visit : 25/Aug/2026
Tests Suggested For Next Visit : EYE TEST FOR DIABETIC RETINOPATHY,AFTER HBA1C / LIPID PROFILE > 2 MTHS
   
   

Dr Tejal Lathia
M.D, D.M (Endocrinology)
Maharashtra / 2003/05/2166

This is a Computer generated Prescription

Powered By: